SciLifeLab’s CRISPR Functional Genomics (CFG) infrastructure unit has played an essential role in aiding the development of GeneAbacus, a ready-to-use gene editing analysis kit soon… Read More »Industry case: SciLifeLab infrastructure essential for Countagen to develop a same-day analysis kit for gene editing
Scientists from the drug discovery company Sprint Bioscience and researchers from MAX IV used X-ray crystallography to take important steps toward developing new and more efficient cancer drugs. The… Read More »Industry case: New cancer drugs developed with the help of X-ray crystallography Industry case:
MAX IV Laboratory beam lines On February 21st, two weeks before the next deadline for calls for MAX IV beamtime, Alexandr Talyzin at Umeå University held a… Read More »Inspirational webinar on synchrotron studies by Alexandr Talyzin
The infrastructure at SciLifeLab is a prerequisite for Key2Brain’s operations. The start-up company Key2Brain develops small antibody fragments which, when coupled with other proteins or… Read More »Industry case: SciLifeLab Infrastructure A Prerequisite for Key2Brain’s Development of Antibody Fragments for Brain Transport of Therapeutics
Speximo AB and MAX IV Laboratory used the unique properties of synchrotron light combined with SAXS and WAXS techniques to obtain new information on the… Read More »Industry case: Stable emulsions under X-rays
Alligator Bioscience in collaboration with SARomics Biostructures used X-ray crystallography to unveil the unique characteristics of one of their antibody-drug candidates, proving how valuable synchrotron… Read More »Industry case: “How biological drug development benefits from photons”
InfraLife took the opportunity to ask Annika Jenmalm Jensen, Infrastructure Director at SciLifeLab and newly elected board member at MAX IV, three quick questions about the new position. Tell us… Read More »InfraLife meets new MAX IV board member Annika Jenmalm Jensen
BoneSupport AB and scientists from Lund University used X-ray tomography to observe how the bone substitute produced by the company behaves inside the bone. They… Read More »Industry case: “Discover the true potential of your biomaterial with X-rays”
As a result of a long-term collaboration between the SciLifeLab Swedish NMR (Nuclear magnetic resonance) centre and AstraZeneca, advanced Dynamic Nuclear Polarization (DNP) NMR is… Read More »Industry case: “Breakthrough high sensitivity NMR technique available through SciLifeLab/AstraZeneca collaboration”
By using a combination of paper and polymer microfluidics, Capitainer has made it possible for everyone to obtain a precise volume of blood from a… Read More »Industry case: “Quantitative mass testing from blood possible in the near future”